Skip to main content
Mindy (Grunzke) Simpson, MD, Pediatric Hematology & Oncology, Chicago, IL, Rush University Medical Center

MindyL.(Grunzke)SimpsonMD

Pediatric Hematology & Oncology Chicago, IL

Pediatric Coagulation Disorder Hematology, Pediatric Platelet Disorder Hematology

Assistant Professor, Pediatrics, Rush Medical College of Rush Univ

Dr. Simpson is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Simpson's full profile

Already have an account?

Summary

  • Dr. Mindy Simpson is a pediatric hematologist/oncologist in Chicago, IL and is affiliated with multiple hospitals in the area, including Rush University Medical Center and Rush-Copley Medical Center. She received her medical degree from Lewis Katz School of Medicine at Temple University and has been in practice 14 years. She specializes in pediatric coagulation disorder hematology and pediatric platelet disorder hematology and is experienced in platelet disorders, hemophilia a, hemophilia, pediatric coagulation disorders, and pediatric hematology and oncology. She has more than 20 publications and over 500 citings.

Education & Training

  • University of Colorado
    University of ColoradoFellowship, Pediatric Hematology/Oncology, 2007 - 2010
  • McGaw Medical Center of Northwestern University
    McGaw Medical Center of Northwestern UniversityResidency, Pediatrics, 2003 - 2006
  • Lewis Katz School of Medicine at Temple University
    Lewis Katz School of Medicine at Temple UniversityClass of 2003

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 2003 - 2026
  • CO State Medical License
    CO State Medical License 2007 - 2011
  • American Board of Pediatrics Pediatrics
  • American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Extended Interval Prophylaxis with Bay 94-9027 for > 4 Years Leads to Median Spontaneous Annualized Bleeding Rates < 1 in the Protect VIII Extension 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • Study Suggests Another Look at Common Treatments for Hemophilia
    Study Suggests Another Look at Common Treatments for HemophiliaJune 13th, 2016

Hospital Affiliations